What is Trebor?
Trebor, Inc. operates within the specialized niche of providing parent rolls of tissue and comprehensive services for the production and conversion of tissue products. The company's core business revolves around supporting clients engaged in the tissue manufacturing sector, offering them customized solutions designed to optimize their production and conversion processes. With a strategic operational footprint that includes corporate headquarters in Matawan, NJ, and an additional West Coast office, Trebor is well-positioned to serve a broad client base, encompassing both domestic East Coast markets and international clients. The company's dedicated team leverages deep expertise in tissue production and conversion to deliver value and support to its clientele.
How much funding has Trebor raised?
Trebor has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Trebor
PPP
Public-Private Partnership
What's next for Trebor?
The substantial capital infusion, highlighted by the $350K in overall financing and the recent $350K strategic investment, positions Trebor for accelerated growth and enhanced market penetration. This late-stage funding context suggests the company is likely focused on expanding its operational capacity, potentially through acquisitions or significant capital expenditures in new technologies or facilities. Furthermore, the strategic nature of the recent backing may indicate a deepening partnership with investors who bring not only capital but also industry expertise and strategic guidance. Trebor is expected to leverage these resources to solidify its market leadership, innovate its service offerings, and potentially explore new geographic markets or product lines within the tissue industry.
See full Trebor company page
